| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07342491 Dasatinib for HIV-1 Reservoir Reduction |
Recruitment opened |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
Trial completed |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
date change Completion moved earlier: 2026-10-03 -> 2026-03-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04877522 | Asciminib Roll-over Study | Chronic Myelogenous Leukemia | Recruiting |
| Phase 3 | |||
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT04530565 | Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or… | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Active, Not Recruiting |
| NCT04971226 | A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+… | Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05653258 | Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older… | Obesity | Recruiting |
| Phase 2 | |||
| NCT06940297 | Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or… | Recurrent Multiple Myeloma | Recruiting |
| NCT05007873 | ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or… | Chronic Phase Chronic Myelogenous Leukemia | Recruiting |
| NCT06055621 | Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients… | Acute Myeloid Leukemia | Recruiting |
| NCT03297606 | Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) | Lymphoma, Non-Hodgkin | Recruiting |
| NCT02559778 | Pediatric Precision Laboratory Advanced Neuroblastoma Therapy | Neuroblastoma | Recruiting |
| NCT06390319 | Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06533748 | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06124157 | A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04747912 | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With… | Lymphoblastic Leukemia | Recruiting |
| NCT02689440 | Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or… | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| NCT07493408 | Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem… | Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) | Not Yet Recruiting |
| NCT03516279 | Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With… | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| NCT04329325 | Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT05838560 | Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders | Schizophrenia | Active, Not Recruiting |
| NCT06018467 | Senolytics to Improve Osteoporosis Therapy | Osteopenia, Osteoporosis | Active, Not Recruiting |
| NCT02143414 | Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT00070499 | Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic… | Chronic Myeloid Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| NCT00792948 | Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT07144293 | Improving Physical Ability and Cellular Senescence Elimination in HIV | HIV | Active, Not Recruiting |
| NCT02465060 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced… | Advanced Lymphoma | Active, Not Recruiting |